Protective effect of thioredoxin upon NO-mediated cell injury in THP1 monocytic human cells.
Although NO has been postulated to play important roles in host defences, it is potentially damaging for exposed cells, including for the macrophages producing the NO. Thus a network of radical acceptors and enzymes is thought to play an important redox-buffering role to protect cells against NO-mediated injury. We examined the properties of the redox systems superoxide dismutase (SOD)/catalase, glutathione (GSH) and thioredoxin (Trx), in regulating the viability of two human monocytic cell lines (THP1 and U937) exposed to the NO-generating compound diethylene triamine-nitric oxide (DETA-NO). We observed that NO-induced cytotoxic effects were time- and dose-dependent towards the two cell lines. After vitamin-induced differentiation in vitro with retinoic acid (RA) and 1,25-dihydroxy vitamin D(3) (VD), termed RA/VD, we observed that THP1 RA/VD cells became more resistant to NO-mediated cytotoxicity whereas the susceptibility of U937 cells was not modified. Using Western blotting and reverse-transcriptase PCR methods, we observed that gene transcription and protein expression of Trx and thioredoxin reductase were significantly increased upon RA/VD treatment and differentiation in THP1 cells. By contrast, SOD/catalase and GSH redox state remained unmodified. Finally, a stable transfectant THP1 line overexpressing Trx was found to be more resistant than THP1 control cells that were untransfected or transfected with an empty plasmid, when exposed to DETA-NO in vitro. In conclusion, we observed an inverse correlation between cell susceptibility to NO damaging effects and Trx expression, suggesting that the Trx system may have important preventative capacities towards NO-mediated cellular injury in monocytic macrophage cells.
Ferret
P J
PJ
Laboratoire INSERM Unité 477, Pavillon Hardy, Hôpital Cochin, 27 rue du Fbg St Jacques, 75674 Paris cedex 14, France.
Soum
E
E
Negre
O
O
Wollman
E E
EE
Fradelizi
D
D
D017209:Apoptosis / Q000502:physiology; D001483:Base Sequence; D002374:Catalase / Q000235:genetics; D002454:Cell Differentiation / Q000187:drug effects; D002460:Cell Line; D017931:DNA Primers; D006801:Humans; D009000:Monocytes / Q000166:cytology / Q000187:drug effects* / Q000201:enzymology; D009569:Nitric Oxide / Q000502:physiology*; D012333:RNA, Messenger / Q000235:genetics; D013482:Superoxide Dismutase / Q000235:genetics; D013879:Thioredoxins / Q000494:pharmacology*; D014212:Tretinoin / Q000494:pharmacology; D015854:Up-Regulation; D014807:Vitamin D / Q000494:pharmacology
D017931:DNA Primers; D012333:RNA, Messenger; D014807:Vitamin D; D009569:Nitric Oxide; D013879:Thioredoxins; D014212:Tretinoin; D002374:Catalase; D013482:Superoxide Dismutase